AI steps in to help babies battling drug withdrawal
NCT ID NCT06303986
Summary
This study aims to collect data to develop an artificial intelligence (AI) tool for newborns with Neonatal Abstinence Syndrome (NAS), a condition caused by drug exposure before birth. Researchers will gather information from 100 babies—80 with NAS and 20 healthy babies—to train the AI to predict symptoms and automate scoring. The goal is to create a more objective monitoring system to help guide care and potentially reduce hospital stays.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL ABSTINENCE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of New Mexico
Albuquerque, New Mexico, 87106, United States
Conditions
Explore the condition pages connected to this study.